insmed inc (INSM:NASDAQ CM)
insmed inc (INSM) Snapshot
|
Open
$12.80
|
Previous Close
$12.76
|
|
|
Day High
$12.85
|
Day Low
$11.96
|
|
|
52 Week High
05/30/13 - $14.30
|
52 Week Low
06/22/12 - $2.86
|
|
|
Market Cap
388.9M
|
Average Volume 10 Days
401.1K
|
|
|
EPS TTM
$-1.66
|
Shares Outstanding
31.8M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
insmed inc (INSM) Related Businessweek News
No Related Businessweek News Foundinsmed inc (INSM) Details
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company’s Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
insmed inc (INSM) Top Compensated Officers
insmed inc (INSM) Key Developments
Insmed Incorporated announced that the Andrea Holtzman Drucker, the Senior Vice President, General Counsel and Corporate Secretary will cease to be employed by the company, effective as on June 3, 2013.
Insmed Incorporated Presents at Merrill Lynch 2013 Health Care Conference, May-16-2013 11:20 AM. Venue: Encore at Wynn, 3121 Las Vegas Blvd South, Las Vegas, Nevada, United States. Speakers: William H. Lewis, Chief Executive Officer, President and Director.
Insmed Incorporated Presents at UBS Global Healthcare Conference, May-20-2013 02:00 PM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Andrew T. Drechsler, Chief Financial Officer and Principal Accounting Officer, William H. Lewis, Chief Executive Officer, President and Director.
| Recently Viewed | |||
| INSM:US | $12.23 USD | -0.53 |  |
| Company | Last | Change |
| Forest Laboratories Inc | $41.84 USD | +0.27 |
| Gilead Sciences Inc | $50.60 USD | -1.34 |
| Novartis AG | SFr.67.15 CHF | 0.00 |
| View Industry Companies | ||
Industry Analysis
INSM
Industry Average
| Valuation | INSM | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 3.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact INSMED INC, please visit www.insmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
